Dar es Salaam. Despite the decision by US President Donald Trump to halt foreign development aid, which threatens the availability of free HIV/AIDS antiretroviral (ARV) drugs, stakeholders remain hopeful that these drugs will continue to be accessible.
These hopes are based on the fact that the US is not the sole source of funding and supply for drugs, with the Global Fund and other partners within the World Health Organization (WHO) also playing a role in their provision.
